These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
825 related articles for article (PubMed ID: 34421350)
21. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849 [TBL] [Abstract][Full Text] [Related]
22. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response. Jiang H; Ning G; Wang Y; Lv W Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187 [TBL] [Abstract][Full Text] [Related]
23. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Li Q; Ni Y; Zhang L; Jiang R; Xu J; Yang H; Hu Y; Qiu J; Pu L; Tang J; Wang X Signal Transduct Target Ther; 2021 Feb; 6(1):76. PubMed ID: 33619246 [TBL] [Abstract][Full Text] [Related]
24. The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 production. Dong W; Dai ZH; Liu FC; Guo XG; Ge CM; Ding J; Liu H; Yang F EBioMedicine; 2019 Jul; 45():155-167. PubMed ID: 31235426 [TBL] [Abstract][Full Text] [Related]
25. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression. Wang L; Long H; Zheng Q; Bo X; Xiao X; Li B Mol Cancer; 2019 Jul; 18(1):119. PubMed ID: 31324186 [TBL] [Abstract][Full Text] [Related]
26. A Comprehensive Insight and In Silico Analysis of CircRNAs in Hepatocellular Carcinoma: A Step toward ncRNA-Based Precision Medicine. Youness RA; Hassan HA; Abaza T; Hady AA; El Magdoub HM; Ali M; Vogel J; Thiersch M; Gassmann M; Hamdy NM; Aboouf MA Cells; 2024 Jul; 13(15):. PubMed ID: 39120276 [TBL] [Abstract][Full Text] [Related]
27. The comprehensive expression and functional analysis of m6A modification "readers" in hepatocellular carcinoma. Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L Aging (Albany NY); 2022 Aug; 14(15):6269-6298. PubMed ID: 35963644 [TBL] [Abstract][Full Text] [Related]
28. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis. Chen M; Wong CM Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216 [TBL] [Abstract][Full Text] [Related]
29. CircCAMSAP1 promotes hepatocellular carcinoma progression through miR-1294/GRAMD1A pathway. Luo Z; Lu L; Tang Q; Wei W; Chen P; Chen Y; Pu J; Wang J J Cell Mol Med; 2021 Apr; 25(8):3793-3802. PubMed ID: 33484498 [TBL] [Abstract][Full Text] [Related]
30. Identification of Novel RNA Binding Proteins Influencing Circular RNA Expression in Hepatocellular Carcinoma. Razpotnik R; Nassib P; Kunej T; Rozman D; Režen T Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299096 [TBL] [Abstract][Full Text] [Related]
31. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance. Lin H; Wang Y; Wang P; Long F; Wang T Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942 [TBL] [Abstract][Full Text] [Related]
32. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway. Huang G; Liang M; Liu H; Huang J; Li P; Wang C; Zhang Y; Lin Y; Jiang X Cell Death Dis; 2020 Dec; 11(12):1065. PubMed ID: 33311442 [TBL] [Abstract][Full Text] [Related]
33. Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival. Li Y; Qi D; Zhu B; Ye X Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540684 [TBL] [Abstract][Full Text] [Related]
34. Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model. Zhang Y; Zeng F; Zeng M; Han X; Cai L; Zhang J; Weng J; Gao Y Int J Biol Sci; 2021; 17(13):3554-3572. PubMed ID: 34512165 [No Abstract] [Full Text] [Related]
35. Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma. Qiu L; Huang Y; Li Z; Dong X; Chen G; Xu H; Zeng Y; Cai Z; Liu X; Liu J Mol Oncol; 2019 Feb; 13(2):441-455. PubMed ID: 30537115 [TBL] [Abstract][Full Text] [Related]
36. RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway. Qiao K; Liu Y; Xu Z; Zhang H; Zhang H; Zhang C; Chang Z; Lu X; Li Z; Luo C; Liu Y; Yang C; Sun T Angiogenesis; 2021 Feb; 24(1):83-96. PubMed ID: 32920668 [TBL] [Abstract][Full Text] [Related]
37. Circular RNA expression and circPTPRM promotes proliferation and migration in hepatocellular carcinoma. Luo Z; Mao X; Cui W Med Oncol; 2019 Sep; 36(10):86. PubMed ID: 31494761 [TBL] [Abstract][Full Text] [Related]
38. CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression. Su Y; Lv X; Yin W; Zhou L; Hu Y; Zhou A; Qi F Aging (Albany NY); 2019 Oct; 11(19):8183-8203. PubMed ID: 31581132 [TBL] [Abstract][Full Text] [Related]
39. A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma. Duan JL; Chen W; Xie JJ; Zhang ML; Nie RC; Liang H; Mei J; Han K; Xiang ZC; Wang FW; Teng K; Chen RX; Deng MH; Yin YX; Zhang N; Xie D; Cai MY Mol Cancer; 2022 Apr; 21(1):93. PubMed ID: 35366894 [TBL] [Abstract][Full Text] [Related]
40. Circular RNA hsa_circRNA_103809 promoted hepatocellular carcinoma development by regulating miR-377-3p/FGFR1/ERK axis. Zhan W; Liao X; Chen Z; Li L; Tian T; Yu L; Wang W; Hu Q J Cell Physiol; 2020 Feb; 235(2):1733-1745. PubMed ID: 31317555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]